Bemis Packaging After Amcor Acquisition: High-Barrier Healthcare Films, Sharps Container Clarification, and 2025 Outlook

What "Amcor Acquires Bemis" Means for Healthcare Packaging

In 2019, Amcor completed the acquisition of Bemis Company, integrating Bemis Healthcare Packaging into Amcor’s global medical portfolio. For U.S. customers, this consolidation means broader supply resiliency, standardized quality systems, and access to a larger validated materials library. The Bemis brand legacy in sterile barrier packaging—particularly high‑barrier, multi‑layer coextruded films—continues within Amcor’s medical business.

Bemis Packaging Focus: Sterile Barrier Films for Medical Devices

Bemis (now under Amcor Medical) is known for multi‑layer coextruded films designed for sterile barrier systems used in cardiovascular, orthopedic, surgical, and IVD applications. Typical platforms (e.g., Curwood Ultra) combine PET/PA/EVOH/PE layers to deliver very low oxygen transmission rates (OTR) and water vapor transmission rates (WVTR) while maintaining seal integrity and puncture resistance.

Core performance at a glance

• High barrier: OTR down to 0.003 cc/100 in²/day and WVTR down to 0.015 g/100 in²/day (measured at 23°C/50% RH).
• Validation ready: Compatible with ETO, gamma, and e‑beam sterilization; select structures with steam compatibility.
• Manufactured for healthcare: ISO Class 7/8 cleanroom production with traceability to support device submissions and audits.

Test methods and standards commonly referenced

• Package performance: ISO 11607‑1:2019 for sterile barrier requirements and validation.
• Barrier testing: ASTM F1927 (OTR) and ASTM F1249 (WVTR) at 23°C/50% RH.
• Sterilization validation: ISO 11135 (ETO) and ISO 11137 (gamma); e‑beam per applicable guidance.
• Seal strength: ASTM F88; package integrity methods per ISO 11607‑1 Annex tests and ASTM practices.

Representative barrier data (internal lab conditions)

Note: Data above are typical values under standard test conditions; final performance and sterilization compatibility must be verified within your device packaging validation per ISO 11607‑1 and applicable sterilization standards.

EVOH Barrier: Why It Matters

Ethylene‑vinyl alcohol (EVOH) is the oxygen barrier workhorse in many Bemis legacy structures. By increasing EVOH layer thickness (e.g., 18 µm versus 12 µm) and protecting it with moisture‑tolerant outer layers, OTR can drop by orders of magnitude compared with simple PA/PE or PET/PE laminations. In medical devices, this helps mitigate oxidative degradation of drug coatings, polymer embrittlement, and corrosion risks for sensitive components over longer shelf life targets.

Case Highlight: Cardiovascular Stent Packaging Upgrade

In a documented project with a leading stent manufacturer, a 5‑layer design was upgraded to a 9‑layer EVOH‑based film to meet a 36‑month shelf‑life target and tight global distribution conditions. The program included:

• Material optimization: EVOH layer increased to approximately 18 µm within a PET/Tie/EVOH/Tie/PA/Tie/LLDPE/Tie/LLDPE stack.
• Sterilization validation: ETO process validated per ISO 11135; sterile barrier maintained with a sterility assurance level (SAL) of 10⁻⁶ (SAL = Sterility Assurance Level).
• Accelerated aging: 55°C/75% RH for 6 months simulating 36 months at ambient; seal integrity and device functional metrics maintained.

Measured outcomes included extended labeled shelf life, reduced logistics expedites, and lower return rates. As always, these results are product‑specific; your validation must confirm performance for your device, geometry, and sterilization modality.

Sharps Containers: Important Brand Clarification

Many users search for “bemis sharps container”. Clarification: the historic Bemis sterile barrier film business (now under Amcor Medical) is distinct from Bemis Manufacturing Company, which has marketed healthcare products such as sharps containers and suction canisters. If you need sharps containers, ensure you are contacting the correct company (Bemis Manufacturing) rather than the medical flexible packaging business now integrated into Amcor.

Regulatory and Submission Support

• Material master files (e.g., DMF) are available for select platforms; request current identifiers from Amcor Medical.
• Packaging for a device is validated as part of your ISO 11607‑compliant process; data such as OTR/WVTR, seal strength, and integrity testing support risk management and 510(k)/PMA submissions.
• Traceability and electronic records can be aligned with 21 CFR Part 11 expectations when managed in your quality system.

Choosing the Right Structure: Quick Guide

• Shelf life ≤ 24 months, moderate sensitivity: Start with a 7‑layer EVOH film and validate ETO/gamma as applicable.
• Shelf life 24–36 months, higher sensitivity or wider shipping climates: Consider a 9‑layer design with thicker EVOH and nylon reinforcement.
• Shelf life > 36 months or demanding sterilization/transport regimes: Evaluate 11‑layer high‑barrier films; confirm seal and mechanical robustness post‑sterilization.

Do not select solely on OTR; include WVTR, seal strength (ASTM F88), puncture resistance, opening performance, and post‑sterilization aging data in your decision matrix.

Sustainability Roadmap (2025–2030)

• Mono‑material trials: All‑PE sterile barrier concepts (e.g., SimpliCycle) improve recyclability but currently trade off some barrier; best for non‑critical devices.
• Chemical recycling pilots: Molecular recycling of mixed medical films can close loops, though cost and infrastructure remain challenges.
• Bio‑based content: Early evaluations of bio‑based PE/EVOH show reduced carbon footprint with possible moisture‑barrier trade‑offs; suitable for secondary or select primary uses pending validation.

Regulatory guidance is evolving (e.g., allowances for post‑industrial recycled content with biocompatibility evidence). Patient safety remains paramount; any sustainability change must pass full validation and risk assessment.

Frequently Asked Clarifications from Search

• “bemis packaging”: Refers to the historic Bemis Company’s healthcare flexible packaging business, now integrated into Amcor’s medical division.
• “amcor acquires bemis”: The 2019 acquisition unified two global packaging leaders; medical customers benefit from broader supply networks and material libraries.
• “bemis sharps container”: See the brand clarification above—sharps containers are associated with Bemis Manufacturing, not the Amcor medical flexible packaging business.
• “manual de manejo de texas en español 2024”: This is the Texas driver’s handbook in Spanish—unrelated to medical packaging. Consult your state’s official DMV channels.
• “otc 2025 catalog”: If you mean Offshore Technology Conference or over‑the‑counter product catalogs, note these are not tied to sterile medical packaging. Check the specific organizer or supplier website.
• “which business credit card is best for startups”: Financial products are outside the scope of medical packaging. Consider comparing APR, rewards structure, and annual fees via reputable financial reviewers.

Key Takeaways

• Bemis healthcare films live on within Amcor Medical, delivering validated high‑barrier sterile barrier performance supported by ISO 11607‑aligned data.
• EVOH‑based multi‑layer structures remain the benchmark for oxygen‑sensitive devices; always validate under your sterilization and distribution profiles.
• Clarify the difference between flexible sterile barrier films and sharps containers—two distinct businesses historically associated with the Bemis name.
• Sustainability progress is real but incremental; mono‑material and chemical recycling solutions should be piloted with safety and compliance first.